The present invention relates to new compounds of formula I, to pharmaceutical formulations containing the compounds, and to the use of the compounds in the prevention and/or treatment of mGluR5 receptor-mediated disorders.

 
Web www.patentalert.com

> Faced board material having a smooth aesthetically pleasing outer surface and good adhesion of facer to core
~ 00399